Genetic Technologies Limited Stock Price and Value Analysis

Should you buy Genetic Technologies Limited stock? (NasdaqCM:GENE). Let's see how it does in our automated value investing analysis system.

Key Facts

Advertisement helps keep Trendshare free for most readers.

Hold-time calculator

Estimate how long you need to hold Genetic Technologies Limited to reach your target.

Target type
AdvantagesDisadvantagesNeutral
  • This company has amazingly consistent growth!
  • This company is less known than others.
  • This stock looks overpriced.
  • This company is not making money.
  • This company pays no dividend.

Inside the GENE Numbers

GENE Price
(Genetic Technologies Limited stock price per share)
$0.00
[?] PE Ratio versus Sector 100% lower than other Healthcare stocks
[?] PE Ratio versus Industry 0% lower than other Biotechnology stocks
[?] Free Cash Flow Jitter 0%

Related guides: good annual rate of return · high-yield stocks · forecasting earnings growth

Is Genetic Technologies Limited Stock on Sale?

Based on our analysis, we believe that you should not buy Genetic Technologies Limited right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.

Advertisement supports free stock analysis content.

Should You Buy GENE Stock?

Does Genetic Technologies Limited have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.

We don't yet have enough financial history for Genetic Technologies Limited to produce a full worked example. Check back as more data becomes available, or see the current price and research links below.